Skip to main content
Clinical Trials/IRCT2015060621684N2
IRCT2015060621684N2CompletedPhase 2

A randomized clinical trial comparing the efficacy of cognitive behavioral therapy on drug use control and treatment among women drug users on Maintaining Methadone Therapy (MMT)

Vice Chancellor for Research, Shiraz University of Medical Sciences0 sites40 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 55 years (—)
Sex
Female

Inclusion Criteria

  • Being addicted female; being on methadone maintaining therapy for at least 3 months; having a history of relapse during MMT program for at least 3 times over the past one month; completing inform consent; having not a history of severe drug toxicity.
  • Exclusion criteria: Having severe physical and neurological illness;Having severe mental and personality disorders.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice Chancellor for Research, Shiraz University of Medical Sciences

Similar Trials